Cumberland Pharmaceuticals Inc.

Historical 13F Holders

Symbol
CPIX
CUSIP
230770109
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 230770109 since 12/18/2024, largest first.

Filer % of Class Filed
A.J. Kazimi 13G 38.4% 2/9/2026
Event 1/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Ikarian Capital, LLC 13G
4.9% 5/15/2025
Event 3/31/2025
Integrated Core Strategies (US) LLC 13G/A
4.0% 10/30/2025
Event 9/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 38.1 k $299 k
2026 Q2 37 2.47 M $16.0 M
2026 Q1 35 2.76 M $8.97 M
2025 Q4 31 2.96 M $11.8 M
2025 Q3 33 3.41 M $10.6 M
2025 Q2 34 3.68 M $12.3 M
2025 Q1 40 4.28 M $18.1 M
2024 Q4 22 1.84 M $4.36 M
2024 Q3 25 2.04 M $2.61 M
2024 Q2 28 2.08 M $3.18 M
2024 Q1 29 2.19 M $3.67 M
2023 Q4 30 2.21 M $3.91 M
2023 Q3 24 2.21 M $4.17 M
2023 Q2 26 2.40 M $3.52 M
2023 Q1 24 2.45 M $4.77 M
2022 Q4 26 2.54 M $5.70 M
2022 Q3 18 2.45 M $5.89 M
2022 Q2 25 2.71 M $5.62 M
2022 Q1 29 2.90 M $8.17 M
2021 Q4 28 2.84 M $13.2 M
2021 Q3 24 2.77 M $7.43 M
2021 Q2 29 2.94 M $8.36 M
2021 Q1 32 3.23 M $9.77 M
2020 Q4 30 4.66 M $13.7 M
2020 Q3 28 4.03 M $12.9 M
2020 Q2 31 4.14 M $13.8 M
2020 Q1 28 4.68 M $17.0 M
2019 Q4 29 4.51 M $23.2 M
2019 Q3 29 4.48 M $26.6 M
2019 Q2 25 4.77 M $30.4 M
2019 Q1 24 4.93 M $28.6 M
2018 Q4 29 5.04 M $30.8 M
2018 Q3 35 5.38 M $30.7 M
2018 Q2 31 5.39 M $33.0 M
2018 Q1 30 5.45 M $36.4 M
2017 Q4 31 5.43 M $40.1 M
2017 Q3 33 5.42 M $38.3 M
2017 Q2 34 5.45 M $38.3 M
2017 Q1 37 5.53 M $38.4 M
2016 Q4 42 5.50 M $30.3 M
2016 Q3 42 5.42 M $27.1 M
2016 Q2 44 5.24 M $23.6 M
2016 Q1 48 5.22 M $23.4 M
2015 Q4 47 5.13 M $27.0 M
2015 Q3 48 5.21 M $30.1 M
2015 Q2 47 5.20 M $37.2 M
2015 Q1 46 5.47 M $36.4 M
2014 Q4 47 5.81 M $34.8 M
2014 Q3 45 6.36 M $31.4 M
2014 Q2 47 6.71 M $30.2 M
2014 Q1 47 6.72 M $30.2 M